News

Author of The Perimenopause Plan Faye James explains why microdosing a GLP-1 in perimenopause is not recommended.
Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...
Wellness influencer Janelle Rohner reveals she is 'microdosing' GLP-1 medication for weight loss and addresses criticism over ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
After revealing her GLP-1 use, wellness influencer Janelle Rohner says she refunded fans who purchased her classes within the last 11 months ...
Health and wellness influencer Janelle Rohner had been documenting her weight loss journey long before she admitted to using ...
Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...
Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...